|Articles|March 29, 2017
Parteck SRP 80 for Sustained-Release Applications
Finn Bauer talks about Parteck SRP 80, an excipient for direct compression of matrix-based, sustained-release tablets. Parteck SRP 80 won the Excellence in Excipients Award at the 2016 CPhI Pharma Awards.
Advertisement
Finn Bauer talks about Parteck SRP 80, an excipient for direct compression of matrix-based, sustained-release tablets. Parteck SRP 80 won the Excellence in Excipients Award at the 2016 CPhI Pharma Awards.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
2
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
3
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
4
Pharma's Next AI Problem Is Authority
5